Reduction in new-onset diabetes mellitus after renal transplant with erythropoietin-stimulating agents: a retrospective cohort study

ConclusionESA exposure may be associated with a reduced incidence of NODAT in the post-renal transplant population. The role of ESA in preventing NODAT requires further investigation.
Source: Canadian Journal of Kidney Health and Disease - Category: Urology & Nephrology Source Type: research